Abstract: Provided are display devices and methods of driving the same. A display device may include: a display panel, a main sound generator and a sub-sound generator disposed on a surface of the display panel. The main sound generator outputs sound in a first directional mode, and each of the main sound generator and the sub-sound generator outputs sound in a second directional mode. Each directional mode may be a mode in which sound is directed towards a particular viewer’s location.

Abstract: Provided are display devices and methods of driving the same. A display device may include: a display panel, a main sound generator and a sub-sound generator disposed on a surface of the display panel. The main sound generator outputs sound in a first directional mode, and each of the main sound generator and the sub-sound generator outputs sound in a second directional mode. Each directional mode may be a mode in which sound is directed towards a particular viewer's location.

Abstract: The present invention relates to a composition for preventing hair loss or promoting hair growth, comprising ginsenoside Rg4 or a mixture of ginsenosides Rg2, Rg4, Rg6, and Rh1 as an active ingredient. Treatment with ginsenoside Rg4 or the mixture of ginsenosides Rg2, Rg4, Rg6, and Rh1 in human hair follicle dermal papilla cells exhibits a desirable effect of forming three-dimensional spheres capable of inducing hair follicle formation and growth and increasing the size thereof, exhibits a desirable effect of activating Wnt/?-catenin signaling, which is important for hair follicle cell activation and regeneration, and exhibits a desirable effect of increasing the expression levels of ALPL, VCAN, BMP2, and FGF7 genes, which are important for hair follicle formation and growth. Thus, ginsenoside Rg4 or the mixture of ginsenosides Rg2, Rg4, Rg6, and Rh1 can be usefully utilized as a composition for preventing hair loss and promoting hair growth.

Abstract: The present invention relates to a composition, for preventing or treating a fine dust-induced respiratory disease, comprising a mixture (Rgx 365), comprising ginsenosides Rg2, Rg4, Rg6 and Rh1, as an active ingredient, a preparation method thereof, and a functional health food, for preventing or relieving a fine dust-induced respiratory disease, comprising same. The present invention exhibits excellent effects on permeability reduction, reactive oxygen (ROS) generation reduction, leucocyte reduction and cytokine generation reduction in a model for fine dust-induced inflammatory response, and thus can be utilized for preventing and treating a fine dust-induced respiratory disease.

Abstract: Provided are display devices and methods of driving the same. A display device may include: a display panel, a main sound generator and a sub-sound generator disposed on a surface of the display panel. The main sound generator outputs sound in a first directional mode, and each of the main sound generator and the sub-sound generator outputs sound in a second directional mode. Each directional mode may be a mode in which sound is directed towards a particular viewer's location.

Abstract: A light emitting diode display device includes a substrate, a first layer disposed on the substrate, a first transistor disposed on the first layer and including a first gate electrode, and a light emitting diode connected to the first transistor, wherein the first layer may overlap the first gate electrode, and may include a first region including a first material and a second region including a second material different from the first material, the first material may include amorphous silicon doped with impurities, and the second material may include amorphous silicon.

Abstract: Provided are display devices and methods of driving the same. A display device may include: a display panel, a main sound generator and a sub-sound generator disposed on a surface of the display panel. The main sound generator outputs sound in a first directional mode, and each of the main sound generator and the sub-sound generator outputs sound in a second directional mode. Each directional mode may be a mode in which sound is directed towards a particular viewer's location.

Abstract: A composition for preventing or treating an aging-related disease includes a novel decursin derivative as an active ingredient, wherein the novel decursin derivative has exhibited an excellent effect of inhibiting progerin expression and excellent effect of inhibiting binding between progerin and lamin A, and it has been confirmed that the novel decursin derivative prolongs the survival period of animal models in which progerin was induced.

Abstract: A light emitting diode display device includes a substrate, a first layer disposed on the substrate, a first transistor disposed on the first layer and including a first gate electrode, and a light emitting diode connected to the first transistor, wherein the first layer may overlap the first gate electrode, and may include a first region including a first material and a second region including a second material different from the first material, the first material may include amorphous silicon doped with impurities, and the second material may include amorphous silicon.

Abstract: Provided are display devices and methods of driving the same. A display device may include: a display panel, a main sound generator and a sub-sound generator disposed on a surface of the display panel. The main sound generator outputs sound in a first directional mode, and each of the main sound generator and the sub-sound generator outputs sound in a second directional mode. Each directional mode may be a mode in which sound is directed towards a particular viewer's location.

Abstract: A composition for preventing or treating an aging-related disease includes a novel decursin derivative as an active ingredient, wherein the novel decursin derivative has exhibited an excellent effect of inhibiting progerin expression and excellent effect of inhibiting binding between progerin and lamin A, and it has been confirmed that the novel decursin derivative prolongs the survival period of animal models in which progerin was induced.

Abstract: Disclosed is a new compound that inhibits binding between a DX2 protein and a p14/ARF protein, a pharmaceutical composition including the new compound as an effective component for treating or preventing a cancer disease, an anticancer adjuvant for improving an anticancer effect of a drug-resistant anticancer drug, and a composition including an AIMP2-DX2 protein or a fragment thereof for diagnosing lung cancer.

Abstract: A method of manufacturing a transistor display panel and a transistor display panel, the method including forming a polycrystalline silicon layer on a substrate; forming an active layer by patterning the polycrystalline silicon layer; forming a first insulating layer covering the substrate and the active layer; exposing the active layer by polishing the first insulating layer using a polishing apparatus; and forming a second insulating layer that contacts the first insulating layer and the active layer, wherein exposing the active layer by polishing the first insulating layer includes coating a first slurry on a surface of the first insulating layer, the first slurry reducing a polishing rate of the active layer.

Abstract: Disclosed is a new compound that inhibits binding between a DX2 protein and a p14/ARF protein, a pharmaceutical composition including the new compound as an effective component for treating or preventing a cancer disease, an anticancer adjuvant for improving an anticancer effect of a drug-resistant anticancer drug, and a composition including an AIMP2-DX2 protein or a fragment thereof for diagnosing lung cancer.

Abstract: Disclosed is a new compound that inhibits binding between a DX2 protein and a p14/ARF protein, a pharmaceutical composition including the new compound as an effective component for treating or preventing a cancer disease, an anticancer adjuvant for improving an anticancer effect of a drug-resistant anticancer drug, and a composition including an AIMP2-DX2 protein or a fragment thereof for diagnosing lung cancer.

Abstract: A method of manufacturing a transistor display panel and a transistor display panel, the method including forming a polycrystalline silicon layer on a substrate; forming an active layer by patterning the polycrystalline silicon layer; forming a first insulating layer covering the substrate and the active layer; exposing the active layer by polishing the first insulating layer using a polishing apparatus; and forming a second insulating layer that contacts the first insulating layer and the active layer, wherein exposing the active layer by polishing the first insulating layer includes coating a first slurry on a surface of the first insulating layer, the first slurry reducing a polishing rate of the active layer.

Abstract: Disclosed is a new compound that inhibits binding between a DX2 protein and a p14/ARF protein, a pharmaceutical composition including the new compound as an effective component for treating or preventing a cancer disease, an anticancer adjuvant for improving an anticancer effect of a drug-resistant anticancer drug, and a composition including an AIMP2-DX2 protein or a fragment thereof for diagnosing lung cancer.

Abstract: Provided are compounds for inhibiting Snail-p53 binding and therapeutic agents for cancer including the compounds as an effective component. The Snail-p53 binding inhibitors induce expression of p53 in K-Ras mutant cell lines, thereby enabling effective treatment or prevention of K-Ras mutant cancer, such as, pancreatic cancer, lung cancer, cholangioma, and colon cancer, of which diagnosis or treatment is not easy.

Abstract: The present invention provides pyrazole derivative compounds and pharmaceutically acceptable salts thereof. The compounds of the present invention have an excellent effect of preventing and treating osteoporosis.

Abstract: Provided are compounds for inhibiting Snail-p53 binding and therapeutic agents for cancer including the compounds as an effective component. The Snail-p53 binding inhibitors induce expression of p53 in K-Ras mutant cell lines, thereby enabling effective treatment or prevention of K-Ras mutant cancer, such as, pancreatic cancer, lung cancer, cholangioma, and colon cancer, of which diagnosis or treatment is not easy.